View More
Expert faculty discusses FGFR signaling, possible consequences of FGFR alterations in tumor development, and current FGFR testing methods and prognostic value.
An expert’s thoughts on what healthcare professionals need to know about FGFR alterations and targeted therapies for bladder cancer.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.